Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with a versatile and complicated profile, being the fourth most common single cause of death worldwide. Several research groups have been trying to identify possible therapeutic approaches to treat COPD, such as the use of mucoa...
Saved in:
Main Authors: | Elisabetta Pace (Author), Isa Cerveri (Author), Donato Lacedonia (Author), Gregorino Paone (Author), Alessandro Sanduzzi Zamparelli (Author), Rossella Sorbo (Author), Marcello Allegretti (Author), Luigi Lanata (Author), Francesco Scaglione (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study
by: Maria Ferraro, et al.
Published: (2022) -
Palatability Assessment of Carbocysteine Oral Solution Strawberry Taste Versus Carbocysteine Oral Solution Mint Taste: A Blinded Randomized Study
by: Yaguang Peng, et al.
Published: (2022) -
MUCOLYTIC THERAPY IN INFANTS
by: I. V. Davydova, et al.
Published: (2013) -
CARBOCYSTEINE LYSINE SALT MONOHYDRATE IN TREATMENT OF DISEASES OF LOWER RESPIRATORY TRACT IN CHILDREN
by: T. A. Kruchkova
Published: (2013) -
Case Report: Kawasaki disease associated with acute generalized exanthematous pustulosis secondary to carbocysteine
by: Takashi Furuta, et al.
Published: (2024)